TY - JOUR
T1 - FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen)
T2 - Are they reasonable?
AU - Graham, Garry
AU - Day, Richard
AU - Graudins, Andis
AU - Mohamudally, Anthoulla
PY - 2010
Y1 - 2010
N2 - Hepatotoxicity from paracetamol is of great
concern because of the considerable number of patients
who develop severe toxicity from this drug. A group of
senior medical practitioners, academics and scientists were
brought together on June 29 and 30, 2009 by the Food and
Drug Administration of USA (FDA) with the aim of providing
advice on how to limit the number of cases of
hepatotoxicity due to paracetamol in USA.
AB - Hepatotoxicity from paracetamol is of great
concern because of the considerable number of patients
who develop severe toxicity from this drug. A group of
senior medical practitioners, academics and scientists were
brought together on June 29 and 30, 2009 by the Food and
Drug Administration of USA (FDA) with the aim of providing
advice on how to limit the number of cases of
hepatotoxicity due to paracetamol in USA.
U2 - 10.1007/s10787-010-0039-3
DO - 10.1007/s10787-010-0039-3
M3 - Article
SN - 0925-4692
VL - 18
SP - 47
EP - 55
JO - Inflammopharmacology
JF - Inflammopharmacology
IS - 57
ER -